Suzhou Basecare Medical Corp. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vincent Medical Holdings Ltd.

China Isotope & Radiation Corp.

PW Medtech Group Ltd.

Uni-Bio Science Group Ltd.

Essex Bio-Technology Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Shanghai Heartcare Medical Technology Corp. Ltd.

Elegance Optical International Holdings Ltd.

Broncus Holding Corp.

Suzhou Basecare Medical Corp. Ltd.

Kelfred Holdings Ltd.

Why is Suzhou Basecare Medical Corp. Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of 25.17% and Operating profit at -21.19% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -120.60

Negative results in Jun 25

ROCE(HY) Lowest at -20.6%
DEBT-EQUITY RATIO (HY) Highest at -19.56 %
CASH AND EQV(HY) Lowest at HKD 596.29 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -42.53%, its profits have fallen by -22.1%

Underperformed the market in the last 1 year

Even though the market (Hang Seng Hong Kong) has generated returns of 8.25% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -42.53% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Suzhou Basecare Medical Corp. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Suzhou Basecare Medical Corp. Ltd.

-42.53%

0.00

50.17%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

25.17%

EBIT Growth (5y)

-21.19%

EBIT to Interest (avg)

-120.60

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.11

Tax Ratio

1.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.26

EV to EBIT

2.10

EV to EBITDA

2.36

EV to Capital Employed

-0.08

EV to Sales

-1.13

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-3.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at HKD -130.48 MM

RAW MATERIAL COST(Y)

Fallen by -34.54% (YoY

-12What is not working for the Company

ROCE(HY)

Lowest at -20.6%

DEBT-EQUITY RATIO (HY)

Highest at -19.56 %

CASH AND EQV(HY)

Lowest at HKD 596.29 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.14 times

INTEREST(Q)

Highest at HKD 7.71 MM

Here's what is working for Suzhou Basecare Medical Corp. Ltd.

Net Profit

Higher at HKD -130.48 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Raw Material Cost

Fallen by -34.54% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at HKD 24.61 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 24.61 MM has Grown at 13.79%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Suzhou Basecare Medical Corp. Ltd.

Debt-Equity Ratio

Highest at -19.56 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at HKD 7.71 MM

in the last five periods and Increased by 24.94% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Cash and Eqv

Lowest at HKD 596.29 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 1.14 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio